Below the Surface Is Where the Real Work Happens.
Two Platforms. One Clinical Decision. — MNRF at Ministry of Skin is delivered across Vivace and Sylfirm X — chosen because each brings a distinct and clinically significant set of capabilities that together allow our dermatologists to match the most appropriate technology to each patient's specific presentation, concern, and skin tone.
Overview
There is a particular category of skin concern that patients bring to Ministry of Skin having already tried everything available without surgery — the chemical peels, the laser facials, the radiofrequency devices, the microneedling courses. Some of it helped. None of it produced the improvement they were looking for. The acne scars are still there, visible in certain lights. The skin has lost a firmness that no topical treatment has restored. The pores remain enlarged despite every pore-minimising product on the market. The melasma has faded and returned and faded again without ever fully clearing. The treatments they have tried have worked at the skin surface — and the concerns they are trying to address live somewhere below it.
MNRF — Micro-Needling Radiofrequency — is the treatment for this category of concern. It combines two well-evidenced modalities — microneedling for mechanical collagen induction and radiofrequency for deep thermal tissue stimulation — into a single platform that achieves a depth and quality of skin remodelling that neither modality can produce independently. The microneedles create the channels; the radiofrequency energy is delivered at the needle tip, at precisely controlled depths, directly into the dermis and subdermis where the structural changes that matter are initiated. The result is collagen remodelling that reaches the architecture of the skin — not just its surface expression — and produces improvements in firmness, scar depth, pore structure, and skin quality that accumulate over months in a way that reflects genuine structural change rather than temporary surface improvement.
At Ministry of Skin, MNRF is delivered across two platforms — Vivace and Sylfirm X — chosen not because either is universally superior to the other, but because each brings a distinct and clinically significant set of capabilities that together allow our dermatologists to match the most appropriate technology to each patient's specific presentation. Understanding what distinguishes them is important — because the difference between the two is not a matter of brand or generation. It is a matter of what each device can do that the other cannot.
What MNRF Actually Does
The fundamental distinction between MNRF and standard Dermapen microneedling lies in what happens at the needle tip. In conventional microneedling, the needles create micro-channels that trigger a wound-healing response in the surrounding tissue — limited primarily to the immediate vicinity of each channel, and dependent on the body's spontaneous biological response for its clinical effect. In MNRF, the needles deliver radiofrequency energy at the tip — creating discrete zones of controlled thermal stimulation at precisely targeted depths within the dermis and subdermis. These thermal coagulation zones initiate an immediate and sustained collagen contraction and remodelling response that is both more powerful and more structurally comprehensive than the wound-healing response of mechanical needling alone.
The insulation of the needle shaft is the engineering detail that makes MNRF clinically viable across all skin tones. In uninsulated RF microneedling, electrical energy disperses along the length of the needle shaft as it passes through the epidermis, producing thermal damage at the epidermal level that is clinically unacceptable in darker skin tones. The insulated needles used by both Vivace and Sylfirm X at Ministry of Skin confine the radiofrequency energy to the uninsulated tip — concentrating it precisely at the intended dermal or subdermal depth while leaving the overlying epidermis unaffected. This is the specific technical design that makes MNRF safe for Indian skin tones across the full Fitzpatrick spectrum, and the reason that MNRF is used at Ministry of Skin with confidence for patients across all skin types without the heightened risk of post-inflammatory hyperpigmentation that uninsulated devices carry.
The depth at which radiofrequency energy is delivered is adjustable — calibrated by the treating dermatologist based on the indication, the anatomical zone, and the degree of thermal stimulation required. Superficial settings at 0.5–1.5mm address the papillary dermis for skin quality and pore refinement. Mid-dermal settings at 2.0–3.5mm are used for collagen remodelling in acne scarring and firmness improvement. Deep settings at 3.5–4.0mm and beyond target the subdermal fibrous septa for structural skin tightening and early jowl management. The ability to deliver the appropriate depth of stimulation to each zone of the face within the same session — adjusted in real time by a dermatologist — is what makes MNRF at Ministry of Skin a precisely directed clinical treatment rather than a generalised energy application.
MNRF Portfolio
Why the Right Platform Matters
The choice between Vivace and Sylfirm X at Ministry of Skin is a clinical decision — made by your dermatologist based on your specific skin concern, your skin tone, and the treatment outcomes being targeted. In practice, many patients receive both platforms across the course of a programme, because the capabilities they bring are complementary. But understanding what each platform specifically offers is important context for understanding why one or the other — or both — are recommended for you.
Vivace is Ministry of Skin's primary MNRF platform for structural collagen remodelling — used for acne scar revision, skin tightening, pore reduction, and overall skin quality improvement. It delivers bipolar radiofrequency energy through gold-tipped insulated microneedles, with simultaneous red and near-infrared LED light therapy incorporated into each treatment session for additional anti-inflammatory and collagen-stimulatory effect. The gold-tipped needles are clinically significant: gold is the most conductive material used in MNRF delivery, producing consistent, precise thermal coagulation zones at the needle tip with minimal energy dispersion — and its biocompatibility ensures that the needles themselves produce no allergic or reactive response in the surrounding tissue.
Vivace is used at Ministry of Skin for patients with atrophic acne scarring — particularly rolling and boxcar scars where deep collagen stimulation progressively improves the scar architecture from within — for patients with mild to moderate skin laxity and early jowl formation, for enlarged pore treatment, and for patients who want significant improvement in overall skin firmness and texture without the downtime of fractional laser resurfacing. It is among the most powerful non-ablative remodelling treatments available for these indications — and its tolerability profile, with 24–48 hours of redness and mild swelling, makes it one of the most consistently well-received treatments in the Ministry of Skin programme.
Sylfirm X introduces a capability that no other MNRF device in the world currently offers — and the distinction is not a marketing claim. It is a specific technological feature with a clinical significance documented in peer-reviewed literature that changes, in a meaningful way, what MNRF can be used to treat. Where conventional MNRF — including Vivace — delivers radiofrequency in Continuous Wave mode for deep structural collagen stimulation, Sylfirm X offers a second delivery mode: Pulsed Wave. The difference between these two modes is the difference between two fundamentally different biological targets.
Continuous Wave mode delivers sustained radiofrequency energy that produces broad thermal coagulation zones in the dermis — the mechanism underlying all conventional MNRF and the basis of the structural collagen remodelling that makes MNRF effective for scarring, laxity, and skin quality. Pulsed Wave mode delivers brief, repetitive pulses of radiofrequency energy that do not produce sustained broad thermal coagulation — instead targeting, through selective electrothermolysis, the abnormal neovascularisation and the disrupted basement membrane zone that are the structural drivers of melasma and rosacea. This selective targeting of the basement membrane zone is what makes Sylfirm X the only MNRF platform with peer-reviewed clinical evidence for the treatment of melasma — a condition characterised by dysfunctional melanocyte activity concentrated at the dermal-epidermal junction, where the disrupted basement membrane and the abnormal vascularity beneath it sustain the melanin overproduction that makes melasma so resistant to surface-only treatment.
At Ministry of Skin, Sylfirm X is used for patients with melasma — particularly those with a significant vascular component that has not responded adequately to topical depigmentation or superficial laser treatment — for patients with rosacea and persistent facial redness driven by abnormal superficial vasculature, and for patients who need the comprehensive structural collagen remodelling of MNRF alongside the specific basement membrane targeting that Continuous Wave alone cannot provide. It is also used in Continuous Wave mode for acne scar, laxity, and skin quality indications, with the choice between the two platforms in Continuous Wave applications guided by the specific energy delivery characteristics of each device and the individual patient's presentation.
Results, Realistic Expectations, and the Timeline to Understand
MNRF results develop progressively — and the timeline matters enough to be stated clearly. The collagen produced in response to each MNRF session takes weeks to mature, and the full structural expression of that remodelling in the skin surface is not visible until 6–8 weeks after the session that initiated it. The most significant improvement from a course of MNRF sessions — whether for acne scarring, skin tightening, melasma, or pore refinement — is typically apparent at 3–6 months following the final session, as the accumulated collagen remodelling of the entire course reaches its peak expression. Patients who assess their MNRF results at two weeks are not seeing what the treatment will ultimately produce. Patients who assess them at six months almost always feel the programme was worthwhile.
A standard MNRF programme at Ministry of Skin involves 3–6 sessions spaced 4–6 weeks apart, depending on the concern and its severity. For mild to moderate acne scarring or early laxity, meaningful improvement is typically achieved within 3–4 sessions. For more significant scarring, established laxity, or melasma with a strong vascular component, 5–6 sessions are more appropriate. For all indications, the programme is designed in the context of the patient's broader treatment plan — because MNRF at Ministry of Skin is rarely the only treatment in use, and its outcomes are consistently enhanced when paired intelligently with the complementary modalities — Exosome therapy, laser, chemical peels, or injectables — that address the dimensions of the concern that MNRF alone does not cover.
Clients
Testimonials
Frequently Asked Questions
What is the difference between Vivace and Sylfirm X?
Both are insulated RF microneedling platforms that produce deep collagen remodelling for acne scarring, skin tightening, and skin quality improvement. The meaningful distinction is Sylfirm X's Pulsed Wave mode — a radiofrequency delivery mode that selectively targets the abnormal neovascularisation and disrupted basement membrane zone driving melasma and rosacea, for which no other MNRF platform has published clinical evidence. In Continuous Wave mode for structural remodelling, both platforms are highly effective — and the choice between them for these indications is guided by clinical factors that your dermatologist will assess at your consultation. Many patients receive both platforms across the course of their programme, using each for the indications it addresses most specifically.
Is MNRF safe for dark Indian skin?
Yes — and this is one of MNRF's most important clinical advantages for our patient population. The insulated needle design of both Vivace and Sylfirm X confines the radiofrequency energy to the needle tip, leaving the overlying epidermis unaffected and eliminating the thermal epidermal damage that is the primary risk of post-inflammatory hyperpigmentation in darker skin. At Ministry of Skin, MNRF with insulated needles is frequently the preferred primary treatment for acne scarring in patients with Fitzpatrick types V and VI, where ablative laser resurfacing requires more careful management and carries a higher pigmentation risk.
How many MNRF sessions do I need?
For mild to moderate acne scarring, skin quality improvement, or early laxity, 3–4 sessions spaced 4–6 weeks apart typically produces meaningful improvement. For more significant acne scarring, established skin laxity, or melasma with a vascular component, 5–6 sessions are more appropriate. Results continue to develop for 3–6 months following the final session — which is why the full programme is assessed at a review appointment at that point rather than immediately after the last treatment.
What is the downtime after MNRF?
The skin appears red and mildly swollen immediately following an MNRF session — comparable in appearance and sensation to moderate sunburn. Redness typically resolves within 24–48 hours; mild swelling resolves within 24 hours. Most patients feel comfortable returning to social and professional activity within 48 hours, with light makeup applied if preferred. Sun protection at SPF 50+ is non-negotiable from day two onward — which your dermatologist will emphasise at every session, because UV exposure during the collagen remodelling period undermines the structural improvement the treatment is producing.
What is the difference between MNRF and laser resurfacing for acne scars?
MNRF and fractional laser resurfacing address acne scarring through different mechanisms and are most effective when used together rather than compared in isolation. MNRF produces deep, non-ablative collagen remodelling with minimal downtime and very low risk of post-inflammatory hyperpigmentation in darker skin — making it the preferred foundation treatment for scar programmes in Indian skin. Fractional laser resurfacing produces more rapid and dramatic surface texture improvement through controlled ablation, but involves more downtime and higher pigmentation risk in darker tones. At Ministry of Skin, the most effective approach for moderate to severe acne scarring almost always combines both — with MNRF providing the deep structural remodelling and laser used selectively for the surface refinement that completes the result.
